Cancer patients may require COVID-19 vaccinations more often than the general public, but oncology-specific vaccination guidance is needed, researchers say.

Phase 2 trial results support further development of camizestrant for the treatment of estrogen receptor-positive, HER2-negative breast cancer, according to researchers.

Five-fraction SBRT is “a robust and viable alternative” to conventionally or moderately fractionated radiotherapy for prostate cancer, researchers say.

HealthDay News — Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical, colorectal, lung, and prostate cancers, according to a study ...

Real-world progression-free survival (rwPFS) was 4.9 months from ICI initiation and real-world overall survival (rwOS) was 13.6 months. Survival outcomes after severe immune-related adverse events ...

Researchers investigated whether leptin, as a marker of adiposity, could be a link between advanced prostate cancer and coronary heart disease.

More research is needed to investigate the cause of the decline in cutaneous melanoma incidence among young patients, researchers say.

Interventions to improve health literacy should be further investigated or developed to assist individuals with limited health literacy in navigating the health care system, particularly as it relates ...

Model accurately predicts hepatocellular carcinoma among patients with HCV-related cirrhosis with SVR to DAAs.

The researchers assessed TROP2 expression in 19 patient samples and found that 52% had high TROP2 expression (H-score ≥100; mean 123.6±90; range, 0-248). A post hoc analysis showed that OS positively ...

Despite treatment advancements with the introduction of HDMTX and rituximab, up to half of patients will have disease relapse, and 10%–15% may have primary refractory disease.

Bowel side effects do not differ between patients with localized prostate cancer who receive external beam radiation therapy using protons vs photons, investigators reported in a late-breaking ...